Streetbeat News

Stock Prices

BWV

Blue Water Biotech has acquired six FDA-approved drugs across various treatment areas, leading to an increase in its share price.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:42 am

BWV

Blue Water Biotech has acquired six FDA-approved drugs from WraSer for $8.5 million in cash and 1 million restricted shares. The deal expands Blue Water's product portfolio and strengthens its position in the pharmaceutical market.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:36 am

AAPL

BTCUSD

Apple Inc. has warned decentralized social messaging app Damus of potential removal from the App Store due to non-compliance with guidelines, specifically regarding its integration with the Lightning Network. Twitter co-founder Jack Dorsey criticized Apple's decision, while iStore CEO Joel Teitelbaum criticized Dorsey for not integrating cryptocurrencies into Twitter.

Portfolio Pulse from Mehab Qureshi

June 14, 2023 | 11:30 am

IVA

Inventiva SA (NASDAQ:IVA) announced positive topline results of a Phase 2 clinical study evaluating lanifibranor in patients with NAFLD and type 2 diabetes mellitus. The study achieved the primary efficacy endpoint with a 44% reduction of Intra Hepatic Triglycerides and met multiple secondary metabolic endpoints. IVA shares are up 26.40% at $4.64 during the premarket session.

Portfolio Pulse from Vandana Singh

June 14, 2023 | 11:30 am

BRST

NRDY

RNAZ

Insiders have been aggressively buying shares of TransCode Therapeutics (RNAZ), Nerdy (NRDY), and Broad Street Realty (BRST), indicating their confidence in the companies' prospects. Nerdy recently posted better-than-expected quarterly results, while TransCode Therapeutics reported pricing of a $7 million public offering.

Portfolio Pulse from Lisa Levin

June 14, 2023 | 11:24 am

AMD

AMD shares are trading higher after a report suggests that Amazon's cloud unit is considering using the company's AI chips.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:12 am

TSVT

2Seventy Bio's shares are trading lower after the company paused its phase 1 trial of the Plat-08 study of SC-DARIC33 in acute myeloid leukemia.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:09 am

ACB

Aurora Cannabis reported Q3 sales of $47.34 million, missing the estimated $48.72 million.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:06 am

AAPL

Apple is expected to upgrade all iPhone 15 models to a 48MP primary camera, with Sony providing the sensors. The non-Pro iPhone 15 models could see increased demand due to the higher resolution camera. Supply constraints for parts like cameras may cause potential delays in iPhone 15 production.

Portfolio Pulse from Rounak Jain

June 14, 2023 | 11:06 am

KURA

Kura Oncology announced the pricing of its $100M public offering, selling 5,660,871 shares of common stock at $11.50 per share and pre-funded warrants to purchase 3,034,782 shares at $11.4999 per warrant.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:03 am